Delivery Order SPE2DB22D2007-SPE2DB25FJ2QX
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,818.46 firm fixed-price contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets. The contract has a completion date of July 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in packages of 30 tablets. The contract has a ceiling value of $6,757.44 and a performance period through April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units, with a ceiling value of $1,936.37 and a period of performance through June 30, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is the prime...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in units of 30, with a ceiling value of $1,127.92. The contract is a firm fixed-price delivery order with a performance period extending through June 16, 2025. This order is not set-aside and was competitively awarded. Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packages of 30, with a ceiling value of $3,200.95 and a period of performance through June 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen...
- This is a $1,088.38 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The award is a firm-fixed price contract with a completion date of June 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,553.64, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The contract is a firm fixed-price delivery order, with a period of performance through May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
- This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units, with a ceiling value of $43,951.23. The contract is a Firm Fixed Price Delivery Order with a completion date of June 13, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in units of 30, with a total ceiling value of $1,197.12. It is a Firm Fixed Price Delivery Order contract with a completion date of June 13, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has a completion date of May 29, 2025 and a ceiling value of $1,162.38. It is not a set-aside contract, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2QXDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units, with a total ceiling value of $3,091.06. The contract is a firm fixed-price, non-set-aside award with a period of performance ending on July 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 6/30/25 |